Indrayani Biotech

quarterly
yearly
ParticularsSep '21Dec '21Mar '22Jun '22Sep '22
Revenue29.0715.2517.2525.6342.05
Expenses26.6113.6615.1923.2737.36
EBITDA2.461.592.062.364.69
EBIT2.251.321.881.703.94
Profit Before Tax1.661.151.651.795.26
Net Profit1.661.151.651.795.26
Financial Ratios
Operating Profit Margin8.46%10.43%11.94%9.21%11.15%
Net Profit Margin5.71%7.54%9.57%6.98%12.51%
Earning Per Share (Diluted)0.490.340.480.521.54
Dividends Per ShareNANANANANA
ⓒ 2016-2022 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 3.5.6
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  ICICI PRUDENTIAL |  HDFC |  NIPPON INDIA |  ADITYA BIRLA SUN LIFE |  SBI |  UTI |  FRANKLIN TEMPLETON |  KOTAK MAHINDRA |  IDFC |  DSP |  AXIS |  TATA |  L&T |  SUNDARAM |  PGIM |  INVESCO |  LIC |  JM FINANCIAL |  BARODA PIONEER |  CANARA ROBECO |  HSBC |  IDBI |  INDIABULLS |  MOTILAL OSWAL |  BNP PARIBAS |  MIRAE ASSET |  PRINCIPAL |  BOI AXA |  UNION KBC |  TAURUS |  EDELWEISS |  NAVI |  MAHINDRA |  QUANTUM |  PPFAS |  IIFL |  Quant |  SHRIRAM |  SAHARA |  ITI